Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Research and Development Grants

McGill University

$93,333.00

Bioactives generated from in vitro gut microbial metabolism of cannabinoid extract containing oil: effects on the microbiome, anti-inflammatory and anticancer effects_x000d_

EF 2020-21

Résumé
Cannabinoids, particularly cannabidiol (CBD) have garnered considerable interest in terms of their anti-inflammatory and anticancer potential. However, most research to date has been based on in vitro and animal studies. In vitro studies conducted so far have not taken into consideration the role of digestion and the human gut microbiome in the biotransformation of cannabinoids, a crucial step that occurs prior to cannabinoids and their metabolites reaching their target tissues. The microbiome is known to play a central role in mediating or modulating the effects of ingested compounds and is heavily involved in local and systemic effects, including with respect to inflammation. Animal studies can provide useful insight but are limited in their translation to humans partly due to inherent differences between rodent and human gut microbiota. This study will address these limitations by examining the anti-inflammatory and anticancer effects of cannabinoids and their metabolites in intestinal cells, after they have been subjected to a simulated human gut digestion model involving microbial biotransformation. In addition, the study will explore the effects of ingested cannabinoids on gut microbial profiles, as well as characterize the cannabinoid and other metabolites produced by the microbiota in response to administration of a cannabinoid-rich oil.
Programme
Collaborative Research and Development Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
542004-2019
Name nom
Kubow, Stan
Department département
Human Nutrition, School of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2019
Award amount
93333
Program id
CRDPJ
Program name en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Installment
inst:2 - 2
Partie
1
Nb partie
2
Application title
Bioactives generated from in vitro gut microbial metabolism of cannabinoid extract containing oil: effects on the microbiome, anti-inflammatory and anticancer effects_x000d_
Keyword
NSERC
Application summary
Cannabinoids, particularly cannabidiol (CBD) have garnered considerable interest in terms of their anti-inflammatory and anticancer potential. However, most research to date has been based on in vitro and animal studies. In vitro studies conducted so far have not taken into consideration the role of digestion and the human gut microbiome in the biotransformation of cannabinoids, a crucial step that occurs prior to cannabinoids and their metabolites reaching their target tissues. The microbiome is known to play a central role in mediating or modulating the effects of ingested compounds and is heavily involved in local and systemic effects, including with respect to inflammation. Animal studies can provide useful insight but are limited in their translation to humans partly due to inherent differences between rodent and human gut microbiota. This study will address these limitations by examining the anti-inflammatory and anticancer effects of cannabinoids and their metabolites in intestinal cells, after they have been subjected to a simulated human gut digestion model involving microbial biotransformation. In addition, the study will explore the effects of ingested cannabinoids on gut microbial profiles, as well as characterize the cannabinoid and other metabolites produced by the microbiota in response to administration of a cannabinoid-rich oil.